查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434238

血液培养测试市场：按产品、技术、应用和最终用户划分 - 2023-2030 年全球预测

Blood Culture Test Market by Product (Consumable, Instrument, Software and Services), Technology (Culture-Based Technology, Molecular Technology, Proteomics Technology), Application, End User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2022年血液培养检测市场规模为39.9亿美元，2023年达42.3亿美元，预计到2030年将达到64.4亿美元，复合年增长率为6.17%。

全球血液培养检测市场

主要市场统计
基准年[2022] 39.9亿美元
预计年份 [2023] 42.3亿美元
预测年份 [2030] 64.4亿美元
复合年增长率（%） 6.17%
血液培养检测市场-IMG1

血液培养测试是一种临床诊断程序，用于检测血液中是否存在细菌和真菌等微生物。当医疗保健提供者怀疑患者患有全身性感染疾病（例如败血症或菌血症）时，就会进行血液培养测试。该测试包括从患者身上采集血液样本，并将其在受控环境中培养，以促进存在的任何微生物的生长。血液培养检测是现代医学管理感染疾病的重要工具，通常在医院和参考实验室进行。随着老年人口的增加，血流感染疾病和败血症的盛行率不断增加，增加了对血液培养检测的需求。此外，医疗保健基础设施和诊断技术的改进以及对早期和快速诊断的更多关注增加了血液培养检测的可及性和使用。然而，与先进血液培养检测技术相关的高成本可能会限制市场成长。儘管如此，快速诊断测试的发展以缩短获得结果的时间，以及分子诊断的进步以准确识别病原体，可能为市场创造有利的形势。

区域洞察

美洲的血液培养检测市场正在显着成长，美国对血液培养检测产品的消费和生产做出了巨大贡献。败血症高发生率、完善的医疗基础设施以及成熟市场参与者等因素正在促进该地区的成长。自动化血液培养系统的采用以及快速诊断工具的日益重要性进一步增加了需求。在欧洲、中东和非洲，由于每个国家的经济状况和医疗体係不同，血液培养检测的市场形势也多元。欧洲市场正在经历显着成长，重点是医疗保健环境中的感染控制。同时，中东和非洲是新兴市场，医疗基础设施投资不断增加。欧洲市场受益于强有力的医疗保健政策、高额医疗保健支出以及全球诊断公司的存在。疾病监测计划和遏制抗菌素抗药性的努力也促进了该地区的市场成长。在亚太地区，由于医疗设施的快速改善、健康意识的提高以及政府医疗保健支出的增加，血液培养检测市场预计将呈现快速成长。庞大的人口基数、感染疾病的流行以及不断增加的医院和临床诊断实验室数量进一步促进了亚太市场的成长。

FPNV定位矩阵

FPNV定位矩阵对于评估血液培养检测市场至关重要。我们检视与商务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种详细的分析使用户能够根据自己的要求做出明智的决策。根据评级，供应商被分为四个不同的象限，代表不同的成功程度：前沿 (F)、探路者 (P)、利基 (N) 或重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对血液培养测试市场供应商的现状进行深入而深入的研究。仔细比较和分析供应商在整体收益、客户群和其他关键指标方面的贡献，帮助企业更好地了解其绩效以及在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年期间观察到的累积、分散优势和合併特征等因素。这种扩展的详细程度使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：显示主要企业提供的有关市场的全面资讯。

2- 市场发现：深入研究盈利的新兴市场并分析其在成熟细分市场的渗透率。

3- 市场多样性：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4- 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管核准、专利形势和製造能力进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的智慧见解。

本报告解决了以下关键问题：

1-血液培养检测市场的市场规模与预测是多少？

2-在血液培养测试市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-血液培养检测市场的技术趋势和法律规范是什么？

4-血液培养检测市场主要供应商的市场占有率是多少？

5- 进入血液培养检测市场适合的模式和策略措施有哪些？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血流感染疾病和感染疾病需要照护现场和快速诊断检测
      • 公共和私人医疗保健成本增加，特别是为了改善诊断
      • 政府对临床和实验室报销政策的支持和核准
    • 抑制因素
      • 与受污染的血液培养相关的潜在风险
    • 机会
      • 推动诊断测试和方法的新研发 (R&D) 活动
      • 更多采用自动化血液培养测试
    • 任务
      • 政府对血液培养开发和生产有严格的规范
  • 市场区隔分析
    • 产品：软体的不断进步，增强了血液培养资料分析和报告的自动化
    • 技术：病原体的快速和特异性检测增加了分子技术的重要性
    • 用途：血流感染疾病的流行促进血液培养检测的使用
    • 最终用户：学术研究机构更多地使用血液培养测试，以提高病原体检测的特异性和灵敏度
  • 市场趋势分析
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第六章血液培养检测市场：副产品

  • 消耗品
  • 装置
  • 软体和服务

第七章血液培养检测市场：依技术分类

  • 基于文化的技术
  • 分子技术
  • 蛋白质体学技术

第八章血液培养检测市场：依应用分类

  • 菌血症
  • 真菌病
  • 分枝桿菌检测

第九章血液培养检测市场：依最终用户分类

  • 学术研究所
  • 医院实验室
  • 参考实验室

第十章美洲血液培养检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区血培养检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲血液培养检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强

第14章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Anaerobe Systems, Inc.
    • Autobio Diagnostics Co., Ltd.
    • Becton, Dickinson and Company
    • BINDER GmbH
    • Biobase Biodusty（Shandong）, Co., Ltd.
    • Biomerieux SA
    • Bruker Corporation
    • Danaher Corporation
    • Devyser AB
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • HiMedia Laboratories Pvt. Ltd.
    • Juno Diagnostics, Inc.
    • Neogen Corporation
    • Novartis AG
    • OpGen, Inc.
    • Scenker Biological Technology Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Siemens Healthineers AG
    • T2 Biosystems, Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific, Inc.
    • ZeptoMetrix Corporation
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-035DA3C63738

[189 Pages Report] The Blood Culture Test Market size was estimated at USD 3.99 billion in 2022 and expected to reach USD 4.23 billion in 2023, at a CAGR 6.17% to reach USD 6.44 billion by 2030.

Global Blood Culture Test Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.99 billion
Estimated Year [2023] USD 4.23 billion
Forecast Year [2030] USD 6.44 billion
CAGR (%) 6.17%
Blood Culture Test Market - IMG1

The blood culture test is a clinical diagnostic procedure utilized to detect the presence of microorganisms, such as bacteria or fungi, in the blood. A blood culture test is ordered when a healthcare provider suspects that a patient is suffering from a systemic infection, such as septicemia or bacteremia. This test includes drawing a blood sample from the patient and incubating it in a controlled environment to promote the growth of any microorganisms present. The blood culture test is a vital tool in modern medicine for managing infectious diseases and is routinely performed in hospitals and reference laboratories. The rising prevalence of bloodstream infections and sepsis with an increasing aging population drives the need for blood culture tests. Moreover, improvements in healthcare infrastructure and diagnostic technologies coupled with an increasing focus on early and rapid diagnosis have increased the accessibility and use of blood culture tests. However, the high cost associated with advanced blood culture testing technologies may restrict the market growth. Nevertheless, the development of rapid diagnostic tests to decrease the time-to-results and advancements in molecular diagnostics for precise pathogen identification may create an opportunistic landscape for the market.

Regional Insights

The market for blood culture tests in the Americas is growing significantly, with the United States contributing majorly to both the consumption and production of blood culture test products. Factors such as a high incidence rate of sepsis, well-established healthcare infrastructure, and the presence of established market players contribute to the growth in this region. The adoption of automated blood culture systems and the growing importance of rapid diagnostic tools are driving the demand further. The EMEA region exhibits a diverse market landscape for blood culture tests owing to variances in economic conditions and healthcare systems across countries. Europe represents a significant growth of the market, with a strong emphasis on infection control measures in healthcare settings. The Middle East and Africa, on the other hand, are emerging markets with increasing investments in healthcare infrastructure. The European market benefits from robust healthcare policies, high healthcare expenditure, and the presence of global diagnostic companies. Disease surveillance programs and initiatives to curb antimicrobial resistance are also aiding in market growth in this region. The Asia-Pacific region is anticipated to exhibit a rapid growth rate in the blood culture test market attributed to rapidly improving healthcare facilities, growing health awareness, and increased government healthcare expenditures. The vast population base, the increasing prevalence of infectious diseases, and the rising number of hospitals and clinical diagnostic laboratories are further contributing to the growth of the market in the APAC.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Culture Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Culture Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Culture Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Anaerobe Systems, Inc., Autobio Diagnostics Co., Ltd., Becton, Dickinson and Company, BINDER GmbH, Biobase Biodusty(Shandong), Co., Ltd., Biomerieux SA, Bruker Corporation, Danaher Corporation, Devyser AB, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., HiMedia Laboratories Pvt. Ltd., Juno Diagnostics, Inc., Neogen Corporation, Novartis AG, OpGen, Inc., Scenker Biological Technology Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, T2 Biosystems, Inc., Terumo Corporation, Thermo Fisher Scientific, Inc., and ZeptoMetrix Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumable
    • Instrument
    • Software and Services
  • Technology
    • Culture-Based Technology
    • Molecular Technology
    • Proteomics Technology
  • Application
    • Bacteremia
    • Fungemia
    • Mycobacterial Detection
  • End User
    • Academic Research Laboratories
    • Hospital Laboratories
    • Reference Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Culture Test Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Culture Test Market?

3. What are the technology trends and regulatory frameworks in the Blood Culture Test Market?

4. What is the market share of the leading vendors in the Blood Culture Test Market?

5. Which modes and strategic moves are suitable for entering the Blood Culture Test Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Blood Culture Test Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
      • 5.1.1.2. Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
      • 5.1.1.3. Government Support and Approval Along with Clinical and Lab Reimbursement Policies
    • 5.1.2. Restraints
      • 5.1.2.1. Potential Risk Associated with Contaminated Blood Culture
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
      • 5.1.3.2. Rising Adoption of Automated Blood Culture Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Government Norms in the Development and Production of Blood Cultures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Ongoing advancement in the softwares to enhance automation in blood culture data analysis and reporting.
    • 5.2.2. Technology: Growing significance of molecular technology due to its rapid and specific detection of pathogens
    • 5.2.3. Application: Increasing prevalence of bloodstream infections driving the utilization of blood culture test
    • 5.2.4. End User: Rising utilization of blood culture test by academic research laboratories for to enhance the specificity and sensitivity of pathogen detection
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework
  • 5.10. Client Customization

6. Blood Culture Test Market, by Product

  • 6.1. Introduction
  • 6.2. Consumable
  • 6.3. Instrument
  • 6.4. Software and Services

7. Blood Culture Test Market, by Technology

  • 7.1. Introduction
  • 7.2. Culture-Based Technology
  • 7.3. Molecular Technology
  • 7.4. Proteomics Technology

8. Blood Culture Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bacteremia
  • 8.3. Fungemia
  • 8.4. Mycobacterial Detection

9. Blood Culture Test Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Laboratories
  • 9.3. Hospital Laboratories
  • 9.4. Reference Laboratories

10. Americas Blood Culture Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Culture Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Culture Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
      • 13.3.1.2. BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Accelerate Diagnostics Launches Arc System for Use in Blood Culture Test

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Anaerobe Systems, Inc.
    • 14.1.3. Autobio Diagnostics Co., Ltd.
    • 14.1.4. Becton, Dickinson and Company
    • 14.1.5. BINDER GmbH
    • 14.1.6. Biobase Biodusty(Shandong), Co., Ltd.
    • 14.1.7. Biomerieux SA
    • 14.1.8. Bruker Corporation
    • 14.1.9. Danaher Corporation
    • 14.1.10. Devyser AB
    • 14.1.11. Eli Lilly and Company
    • 14.1.12. F. Hoffmann-La Roche Ltd.
    • 14.1.13. HiMedia Laboratories Pvt. Ltd.
    • 14.1.14. Juno Diagnostics, Inc.
    • 14.1.15. Neogen Corporation
    • 14.1.16. Novartis AG
    • 14.1.17. OpGen, Inc.
    • 14.1.18. Scenker Biological Technology Co., Ltd.
    • 14.1.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 14.1.20. Siemens Healthineers AG
    • 14.1.21. T2 Biosystems, Inc.
    • 14.1.22. Terumo Corporation
    • 14.1.23. Thermo Fisher Scientific, Inc.
    • 14.1.24. ZeptoMetrix Corporation
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD CULTURE TEST MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD CULTURE TEST MARKET DYNAMICS
  • FIGURE 7. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 10. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 14. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BLOOD CULTURE TEST MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 10. BLOOD CULTURE TEST MARKET SIZE, BY CULTURE-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BLOOD CULTURE TEST MARKET SIZE, BY PROTEOMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. BLOOD CULTURE TEST MARKET SIZE, BY BACTEREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BLOOD CULTURE TEST MARKET SIZE, BY FUNGEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BLOOD CULTURE TEST MARKET SIZE, BY MYCOBACTERIAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. BLOOD CULTURE TEST MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. BLOOD CULTURE TEST MARKET LICENSE & PRICING